|
⚲
|
| Eidesis Special Opportunities Master Fund III Ltd | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001467800 |
| Sale | 2009-07-01 ($500.0 M Offered, $51.8 M Sold) |
| Fund | |
| Phone | 2127922170 |
| Address | 500 Fifth Avenue New York, 10111 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Xin Wang | |
| Simon Mikhailovich | |
| Michael Sollott | |
| Gregory Sonis |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Bioverge Funds, Bionaut I, LLC
✚
|
0.0 | |
|
BIOS Fund III, LP
✚
|
0.0 | |
|
BioScience Health Innovations, Inc.
✚
|
0.0 | |
|
Bioseed EGIC Fund LLC
✚
|
0.0 | |
|
Biotechnology Value Fund L P
✚
|
0.0 | |
|
Biotechnology Value Fund II LP
✚
|
0.0 | |
|
Avistone Tech Park, LLC
✚
|
0.0 | |
|
Biotricity Inc
✚
|
0.0 | |
|
Bioventus Inc.
✚
|
0.0 | |
|
Bioverge Funds, Eigen I, LLC
✚
|
0.0 |